Tsutsui H - Search Results

1

Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.

Tsutsui H, Albert NM, Coats AJS, Anker SD, Bayes-Genis A, Butler J, Chioncel O, Defilippi CR, Drazner MH, Felker GM, Filippatos G, Fiuzat M, Ide T, Januzzi JL Jr, Kinugawa K, Kuwahara K, Matsue Y, Mentz RJ, Metra M, Pandey A, Rosano G, Saito Y, Sakata Y, Sato N, Seferovic PM, Teerlink J, Yamamoto K, Yoshimura M. Tsutsui H, et al. Eur J Heart Fail. 2023 May;25(5):616-631. doi: 10.1002/ejhf.2848. Epub 2023 Apr 26. Eur J Heart Fail. 2023. PMID: 37098791 Free article.

2

Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action.

Ide T, Tsutsui H, Kinugawa S, Utsumi H, Takeshita A. Ide T, et al. Among authors: tsutsui h. Circulation. 1999 Aug 17;100(7):690-2. doi: 10.1161/01.cir.100.7.690. Circulation. 1999. PMID: 10449688

3

Positive inotropic effect of insulin-like growth factor-1 on normal and failing cardiac myocytes.

Kinugawa S, Tsutsui H, Ide T, Nakamura R, Arimura K, Egashira K, Takeshita A. Kinugawa S, et al. Among authors: tsutsui h. Cardiovasc Res. 1999 Jul;43(1):157-64. doi: 10.1016/s0008-6363(99)00058-9. Cardiovasc Res. 1999. PMID: 10536700

4

Role of Ca2+ availability to myofilaments and their sensitivity to Ca2+ in myocyte contractile dysfunction in heart failure.

Kinugawa S, Tsutsui H, Satoh S, Takahashi M, Ide T, IgarashiSaito K, Arimura K, Egashira K, Takeshita A. Kinugawa S, et al. Among authors: tsutsui h. Cardiovasc Res. 1999 Nov;44(2):398-406. doi: 10.1016/s0008-6363(99)00205-9. Cardiovasc Res. 1999. PMID: 10690316

5

Treatment with dimethylthiourea prevents left ventricular remodeling and failure after experimental myocardial infarction in mice: role of oxidative stress.

Kinugawa S, Tsutsui H, Hayashidani S, Ide T, Suematsu N, Satoh S, Utsumi H, Takeshita A. Kinugawa S, et al. Among authors: tsutsui h. Circ Res. 2000 Sep 1;87(5):392-8. doi: 10.1161/01.res.87.5.392. Circ Res. 2000. PMID: 10969037

6

Increased inactivation of nitric oxide is involved in coronary endothelial dysfunction in heart failure.

Arimura K, Egashira K, Nakamura R, Ide T, Tsutsui H, Shimokawa H, Takeshita A. Arimura K, et al. Among authors: tsutsui h. Am J Physiol Heart Circ Physiol. 2001 Jan;280(1):H68-75. doi: 10.1152/ajpheart.2001.280.1.H68. Am J Physiol Heart Circ Physiol. 2001. PMID: 11123219 Free article.

7

Increased inactivation of nitric oxide is involved in impaired coronary flow reserve in heart failure.

Nakamura R, Egashira K, Arimura K, Machida Y, Ide T, Tsutsui H, Shimokawa H, Takeshita A. Nakamura R, et al. Among authors: tsutsui h. Am J Physiol Heart Circ Physiol. 2001 Dec;281(6):H2619-25. doi: 10.1152/ajpheart.2001.281.6.H2619. Am J Physiol Heart Circ Physiol. 2001. PMID: 11709431 Free article.

8

Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis.

Jackson CE, Castagno D, Maggioni AP, Køber L, Squire IB, Swedberg K, Andersson B, Richards AM, Bayes-Genis A, Tribouilloy C, Dobson J, Ariti CA, Poppe KK, Earle N, Whalley G, Pocock SJ, Doughty RN, McMurray JJ; Meta-Analysis Global Group in Chronic Heart Failure MAGGIC. Jackson CE, et al. Eur Heart J. 2015 May 7;36(18):1106-14. doi: 10.1093/eurheartj/ehu490. Epub 2015 Jan 23. Eur Heart J. 2015. PMID: 25616644 Free article. Review.

9

Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.

Verma S, Dhingra NK, Butler J, Anker SD, Ferreira JP, Filippatos G, Januzzi JL, Lam CSP, Sattar N, Peil B, Nordaby M, Brueckmann M, Pocock SJ, Zannad F, Packer M; EMPEROR-Reduced trial committees and investigators. Verma S, et al. Lancet Diabetes Endocrinol. 2022 Jan;10(1):35-45. doi: 10.1016/S2213-8587(21)00292-8. Epub 2021 Nov 30. Lancet Diabetes Endocrinol. 2022. PMID: 34861154

10

Nationwide Temporal Trends in Clinical Characteristics and Treatment of Dilated Cardiomyopathy From 2003 to 2013 in Japan　- A Report From Clinical Personal Records.

Tsutsui Y, Matsushima S, Enzan N, Noda E, Shinohara K, Hashimoto T, Ide T, Kinugawa S, Tsutsui H. Tsutsui Y, et al. Among authors: tsutsui h. Circ J. 2023 Mar 24;87(4):500-507. doi: 10.1253/circj.CJ-22-0554. Epub 2023 Feb 16. Circ J. 2023. PMID: 36792220 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,260 results

Search Page